CN1058497C - 7-三烷基甲硅烷基浆果赤霉素ⅲ的制备方法 - Google Patents

7-三烷基甲硅烷基浆果赤霉素ⅲ的制备方法 Download PDF

Info

Publication number
CN1058497C
CN1058497C CN95192429A CN95192429A CN1058497C CN 1058497 C CN1058497 C CN 1058497C CN 95192429 A CN95192429 A CN 95192429A CN 95192429 A CN95192429 A CN 95192429A CN 1058497 C CN1058497 C CN 1058497C
Authority
CN
China
Prior art keywords
baccatin iii
trialkylsilkl
iii
general formula
mole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN95192429A
Other languages
English (en)
Other versions
CN1145073A (zh
Inventor
J·P·巴斯塔特
J·P·莱康特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of CN1145073A publication Critical patent/CN1145073A/zh
Application granted granted Critical
Publication of CN1058497C publication Critical patent/CN1058497C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/188Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epoxy Compounds (AREA)
  • Silicon Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Saccharide Compounds (AREA)
  • Liquid Deposition Of Substances Of Which Semiconductor Devices Are Composed (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
  • Silicon Polymers (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

由10-脱乙酰基浆果赤霉素III制备7-三烷基甲硅烷基浆果赤霉素III的方法。

Description

7-三烷基甲硅烷基浆果赤霉素Ⅲ的制备方法
本发明涉及一种具有下述通式(I)的7-三烷基甲硅烷基浆果赤霉素III的新的制备方法:
Figure C9519242900041
式中符号R可相同或不相同,它代表含有1-4个碳原子的,或许由苯基取代的烷基,所述的7-三烷基甲硅烷基浆果赤霉素III是由具有下述通式的10-脱乙酰基浆果赤霉素III制备的:
在通式(I)中,优选地,这些符号R中的每一个都表示含有1-4个碳原子的直链或支化的烷基。更优选地,这些符号R中的每一个都表示乙基。
具体地由J-N.Denis和A.E.Greene,J.Amer.Chem.Soc.,110,5917-5919(1998)人们知道,以化学式(II)的10-脱乙酰基浆果赤霉素III作为原料,通过首先使塔三烷(taxane)环的7-位选择性甲硅烷基化,得到7-三烷基甲硅烷基-10-脱乙酰基浆果赤霉素III,然后使如此得到的7-三烷基甲硅烷基-10-脱乙酰基浆果赤霉素III在10位选择性乙酰化,制备出通式(I)的产品。
根据已知的方法,用过量的下述通式的三烷基甲硅烷基卤处理10-脱乙酰基浆果赤霉素III进行甲硅烷化基反应:
 Hal-Si(R)3           (III)
其中Hal表示卤素原子,R如前面所定义,这个反应是在诸如吡啶之类的碱性有机溶剂中,于温度约20℃的条件下进行操作的。一般地,可达到7-三烷基甲硅烷基-10-脱乙酰基浆果赤霉素III产率为约85%。
根据已知的方法,在诸如吡啶之类的碱性有机溶剂中,于温度约0℃的条件下进行操作,由过量的乙酰氯处理7-三乙基甲硅烷基-10-脱乙酰基浆果赤霉素III进行乙酰基化。一般地,由7-三乙基甲硅烷基浆果赤霉素III开始,化学式(I)的7-三烷基甲硅烷氧基浆果赤霉素III的产率为约85%。
这样,根据已知的方法,7-三烷基甲硅烷基浆果赤霉素III的产率为约72%。
现在发现,这正构成本发明的主题,不用分离中间产物7-三烷基甲硅烷基-10-脱乙酰基浆果赤霉素III而进行甲硅烷基化和乙酰基化,可以较高的产率得到通式(I)的产品。
根据本发明,10-脱乙酰基浆果赤霉素III在选自吡啶和由一个或多个含有1-4个碳原子的烷基取代的吡啶之类有机碱性溶剂的溶液里,在温度0-15℃下用通式(III)的甲硅烷基化试剂处理,然后在温度约20℃下用乙酐处理。
采用本发明的方法需要使用比已知方法少得多的甲硅烷基化试剂。一般地,相对于每摩尔10-脱乙酰基浆果赤霉素III要使用1.5-2.5摩尔甲硅烷基化试剂。
一般地,相对于每摩尔10-脱乙酰基浆果赤霉素III要使用5-7摩尔乙酐。
7-三烷基甲硅烷基浆果赤霉素III由其在诸如乙酸乙酯之类脂族酯中的溶液开始,用异丙醚之类的醚在水中沉淀和结晶,可以分离7-三烷基甲在浆果赤霉素III。一般地,由使用的10-脱乙酰基浆果赤霉素III开始的产率是约80%。
本发明得到的7-三烷基甲硅烷基浆果赤霉素III在分离后或以诸如乙酸乙酯之类脂族酯溶液形式可根据如EP-0 336 840专利或国际申请WO 92/09589中描述的已知方法用于制备(2R,3S)-3-苯甲酰氨基-2-羟基-3-苯基丙酸4,10-二乙酸基-2α-苯甲酰氧基-5β,20-环氧-1,7β-二羟基-9-氧-紫杉-11-烯-13α-酯或其衍生物。
下面实施例说明实施本发明的方法。实施例
在293.9克在2.7升吡啶中的10-脱乙酰基浆果赤霉素III溶液中,在1小时20分钟加入182克三乙基甲硅烷基氯。所得到的溶液在5℃搅拌40小时。这时加入360克乙酐,同时将温度保持在5℃。得到的悬浮液在20℃搅拌48小时,然后倒入40升冰水。采用过滤分离所得到的沉淀,再用2升水洗涤8次,最后将沉淀溶解在3升乙酸乙酯中。在硫酸镁上干燥有机相。在过滤并减压浓缩后,在异丙醚中结晶所得到的产物。这样得到7-三乙基甲硅烷基浆果赤霉素III,其产率是77%,7-三乙基甲硅烷基浆果赤霉素III具有如下特性:-熔点:254℃-质子核磁共振谱:(400MHz;CDCl3,δ,ppm):0.58(mt,6H:乙基CH2);0.92(t,J=7.5Hz,9H:乙基CH3);1.02(s,3H:CH3);1.18(s,3H:CH3);1.68(s,3H:CH3);1.75(宽的s,1H:在1位的OH);1.87和2.53(2mt,每个1H:在6位的CH2);2.18(s,6H:CH3和COCH3);2.27(mt,2H:在14位的CH2);2.28(s,3H:COCH3);2.47(宽的s,1H:在13位的OH);3.88(d,J=7Hz,1H:H3);4.13和4.30(2d,J=8.5Hz,每个1H:在20位的CH2);4.50(dd,J=11和7Hz,1H:在7位的H);4.81(mt,1H:在13位的H);4.95(宽的d,J=10Hz,1H:在5位的H);5.63(d,J=7Hz,1H:H2);6.46(s,1H:在10位的H);7.46(t,J=8.5Hz,2H:在间位的-OCOC6H5);7.60(t,J=8.5Hz,1H:在-OCOC6H5对位上的H);8.10(d,J=8.5Hz,2H:在-OCOC6H5邻位上的H)。

Claims (10)

1.具有下述通式(I)的7-三烷基甲硅烷基浆果赤霉素III的制备方法:式中R相同或不同,表示C1-4直链或支链烷基,其特征在于用下述通式(III)所示甲硅烷基化试剂处理具有下述通式(II)的10-脱乙酰基浆果赤霉素III:Hal-Si(R)3                       (III)式中Hal表示卤素原子,R如前面所限定,然后用乙酐处理而不用分离中间产物7-三烷基甲硅烷基-10-脱乙酰基浆果赤霉素III。
2.根据权利要求1的方法,其特征在于在碱性有机溶剂中操作。
3.根据权利要求2的方法,其特征在于碱性有机溶剂选自吡啶和被一个或多个含有1-4个碳原子的烷基取代的吡啶。
4.根据权利要求2的方法,其特征在于碱性有机溶剂是吡啶。
5.根据权利要求1的方法,其特征在于相对于每摩尔10-脱乙酰基浆果赤霉素III使用1.5-2.5摩尔甲硅烷基化试剂。
6.根据权利要求1的方法,其特征在于相对于每摩尔10-脱乙酰基浆果赤霉素III使用5-7摩尔乙酐。
7.根据权利要求1的方法,其特征在于在温度0-15℃下用甲硅烷基化试剂进行处理。
8.根据权利要求1的方法,其特征在于在温度约20℃下用乙酐进行处理。
9.权利要求1-8中任一项的方法制备的通式(I)的7-三烷基甲硅烷基浆果赤霉素III,其中每个R符号表示含有1-3个碳原子的烷基。
10.权利要求1-8中任一项的方法制备的通式(I)的7-三烷基甲硅烷基浆果赤霉素III,其中每个R符号表示乙基。
CN95192429A 1994-04-05 1995-04-03 7-三烷基甲硅烷基浆果赤霉素ⅲ的制备方法 Expired - Lifetime CN1058497C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403979A FR2718137B1 (fr) 1994-04-05 1994-04-05 Procédé de préparation de trialcoylsilyl-7 baccatine III.
FR94/03979 1994-04-05

Publications (2)

Publication Number Publication Date
CN1145073A CN1145073A (zh) 1997-03-12
CN1058497C true CN1058497C (zh) 2000-11-15

Family

ID=9461745

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95192429A Expired - Lifetime CN1058497C (zh) 1994-04-05 1995-04-03 7-三烷基甲硅烷基浆果赤霉素ⅲ的制备方法

Country Status (33)

Country Link
US (1) US5670658A (zh)
EP (1) EP0754185B1 (zh)
JP (1) JP3718225B2 (zh)
KR (1) KR100399246B1 (zh)
CN (1) CN1058497C (zh)
AT (1) ATE160351T1 (zh)
AU (1) AU683560B2 (zh)
BG (1) BG62735B1 (zh)
BR (1) BR9507444A (zh)
CA (1) CA2186916C (zh)
CZ (1) CZ288397B6 (zh)
DE (1) DE69501080T2 (zh)
DK (1) DK0754185T3 (zh)
EE (1) EE03240B1 (zh)
ES (1) ES2109103T3 (zh)
FI (1) FI115970B (zh)
FR (1) FR2718137B1 (zh)
GE (1) GEP19991537B (zh)
GR (1) GR3025448T3 (zh)
HU (1) HU214158B (zh)
LT (1) LT4185B (zh)
LV (1) LV11691B (zh)
MX (1) MX9604466A (zh)
NO (1) NO305839B1 (zh)
NZ (1) NZ284490A (zh)
PL (1) PL316588A1 (zh)
RO (1) RO115631B1 (zh)
RU (1) RU2127729C1 (zh)
SK (1) SK280448B6 (zh)
TW (1) TW284765B (zh)
UA (1) UA44730C2 (zh)
WO (1) WO1995026967A1 (zh)
ZA (1) ZA952733B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973160A (en) * 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
ATE234800T1 (de) 1997-08-21 2003-04-15 Univ Florida State Verfahren zur synthese von taxanen
CZ2003837A3 (cs) 2000-09-22 2004-12-15 Bristol-Myers Squibb Company Způsob pro snížení toxicity při kombinovaných chemoterapiích
AU2003273671A1 (en) * 2002-10-09 2004-05-04 Phytogen Life Sciences, Inc. Novel taxanes and methods related to use and preparation thereof
US7202370B2 (en) * 2003-10-27 2007-04-10 Conor Medsystems, Inc. Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
MXPA06012606A (es) * 2004-05-14 2007-01-31 Immunogen Inc Un metodo facil para sintetizar compuestos de bacatina iii.
CZ298333B6 (cs) * 2005-09-26 2007-08-29 Zentiva, A. S Zpusob prípravy 7-trialkylsilylbaccatinu III
KR101671537B1 (ko) 2008-08-11 2016-11-01 넥타르 테라퓨틱스 다분지형 중합체 알카노에이트 컨쥬게이트
WO2012088391A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Non-ring hydroxy substituted taxanes and methods for synthesizing the same
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006094A1 (en) * 1991-09-23 1993-04-01 Florida State University Metal alkoxides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4823167A (en) * 1986-12-16 1989-04-18 Baxter International Inc. Catheter calibration device
FR2629818B1 (fr) * 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5597931A (en) * 1992-03-30 1997-01-28 Sloan-Kettering Institute For Cancer Research Total synthesis of taxol and analogues thereof
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US5405972A (en) * 1993-07-20 1995-04-11 Florida State University Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes
US5449790A (en) * 1994-04-06 1995-09-12 Hauser Chemical Research, Inc. Preparation of 10-deacetylbaccatin III and 7-protected-10-deacetylbaccatin III derivatives from 10-deacetyl taxol A, 10-deacetyl taxol B, and 10-deacetyl taxol C

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006094A1 (en) * 1991-09-23 1993-04-01 Florida State University Metal alkoxides

Also Published As

Publication number Publication date
PL316588A1 (en) 1997-01-20
CA2186916C (fr) 2004-05-25
NO964103D0 (no) 1996-09-27
TW284765B (zh) 1996-09-01
BG62735B1 (bg) 2000-06-30
EP0754185A1 (fr) 1997-01-22
FR2718137B1 (fr) 1996-04-26
HUT76035A (en) 1997-06-30
HU9602735D0 (en) 1996-11-28
HU214158B (hu) 1998-01-28
LV11691A (lv) 1997-02-20
FI964001A0 (fi) 1996-10-04
AU2309695A (en) 1995-10-23
AU683560B2 (en) 1997-11-13
DK0754185T3 (da) 1998-01-26
EE03240B1 (et) 1999-12-15
SK280448B6 (sk) 2000-02-14
FI115970B (fi) 2005-08-31
LV11691B (en) 1997-06-20
RO115631B1 (ro) 2000-04-28
BR9507444A (pt) 1997-09-16
ATE160351T1 (de) 1997-12-15
FR2718137A1 (fr) 1995-10-06
MX9604466A (es) 1997-07-31
CZ288397B6 (en) 2001-06-13
ES2109103T3 (es) 1998-01-01
SK126596A3 (en) 1997-04-09
GEP19991537B (en) 1999-03-05
CA2186916A1 (fr) 1995-10-12
NO305839B1 (no) 1999-08-02
GR3025448T3 (en) 1998-02-27
ZA952733B (en) 1996-01-09
CZ290096A3 (en) 1997-01-15
WO1995026967A1 (fr) 1995-10-12
EP0754185B1 (fr) 1997-11-19
UA44730C2 (uk) 2002-03-15
LT96137A (en) 1997-02-25
DE69501080D1 (de) 1998-01-02
KR100399246B1 (ko) 2004-02-11
NO964103L (no) 1996-09-27
LT4185B (en) 1997-07-25
RU2127729C1 (ru) 1999-03-20
NZ284490A (en) 1998-08-26
BG100886A (en) 1998-01-30
CN1145073A (zh) 1997-03-12
JPH09512522A (ja) 1997-12-16
US5670658A (en) 1997-09-23
DE69501080T2 (de) 1998-04-02
JP3718225B2 (ja) 2005-11-24
FI964001A (fi) 1996-10-04

Similar Documents

Publication Publication Date Title
CN1058497C (zh) 7-三烷基甲硅烷基浆果赤霉素ⅲ的制备方法
CA2569498C (en) Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
CA2204197A1 (en) Process for converting 9-dihydro-13-acetylbaccatin iii into taxol and derivatives thereof
CN101128448A (zh) 制备紫杉醇的方法
JP3878204B2 (ja) パクリタキセル及びパクリタキセル前駆体に至るグリコシド置換化パクリタキセル類の酸化並びに中間体として形成した新規タキサン化合物
AU716876B2 (en) Method for selective protection of baccatin derivatives and its application to taxane synthesis
MXPA01012177A (es) Semi-sintesis de paclitaxel usando dialquildiclorosilanos.
CN101130528A (zh) 浆果赤霉素ⅲ衍生物的制备方法
JP4454310B2 (ja) 14ベータ−ヒドロキシ−バッカチンiii−1,14−カルボネートの調製方法
JPH029585B2 (zh)
US6723849B1 (en) Process for making camptothecin derivatives
CN103936685B (zh) 3‑三苯并三氮唑甲烷取代‑1‑(1,3‑二烷基)丙烯类化合物及其合成方法
CN1482251A (zh) 生物催化紫杉醇侧链手性合成与紫杉醇半合成
JPS6236334A (ja) 水酸基の脱保護法
JPH03246289A (ja) 光学活性なバレロラクトン誘導体
JPH0819038B2 (ja) (3,5―ジヒドロキシ―2―メチレンシクロヘキシリデン)酢酸エステル類の製造法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: AVENTIS PHARMA S.A.

Free format text: FORMER NAME OR ADDRESS: RHONE-POULENC RORER S.A.

CP03 Change of name, title or address

Address after: French Anthony

Patentee after: Awentis Pharmaceutical S. A.

Address before: French Anthony

Patentee before: Rhone-Poulenc Rorer S. A.

C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20150403

Granted publication date: 20001115